List of Excipients in API doxepin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxepin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-4810 | CELLULOSE, MICROCRYSTALLINE | |
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-4810 | FD&C BLUE NO. 1 | |
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-4810 | MAGNESIUM STEARATE | |
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-4810 | SILICON DIOXIDE | |
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-8117 | BENZYL ALCOHOL | |
| Mylan Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | 0378-8117 | CETYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxepin hydrochloride
Detailed excipient profiles for doxepin hydrochloride
Excipient focus: ALCOHOL
doxepin hydrochloride drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | doxepin hydrochloride | 21695-441 |
| Leading Pharma LLC | doxepin hydrochloride | 69315-158 |
| Leading Pharma LLC | doxepin hydrochloride | 69315-163 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing ALCOHOL
Excipient focus: AMMONIA
doxepin hydrochloride drug variants containing AMMONIA
doxepin hydrochloride drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
doxepin hydrochloride drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZYL ALCOHOL
doxepin hydrochloride drug variants containing BENZYL ALCOHOL
doxepin hydrochloride drug variants not containing BENZYL ALCOHOL
Excipient focus: BUTYL ALCOHOL
doxepin hydrochloride drug variants containing BUTYL ALCOHOL
doxepin hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxepin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
doxepin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETYL ALCOHOL
doxepin hydrochloride drug variants containing CETYL ALCOHOL
doxepin hydrochloride drug variants not containing CETYL ALCOHOL
Excipient focus: CITRIC ACID MONOHYDRATE
doxepin hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSPOVIDONE
doxepin hydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | doxepin hydrochloride | 51407-811 |
| Strides Pharma Science Limited | doxepin hydrochloride | 64380-204 |
| Novadoz Pharmaceuticals LLC | doxepin hydrochloride | 72205-052 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
doxepin hydrochloride drug variants containing D&C YELLOW NO. 10
doxepin hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxepin hydrochloride drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | doxepin hydrochloride | 69315-158 |
| Leading Pharma LLC | doxepin hydrochloride | 69315-163 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1
doxepin hydrochloride drug variants containing FD&C BLUE NO. 1
doxepin hydrochloride drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
doxepin hydrochloride drug variants containing FD&C BLUE NO. 2
doxepin hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
doxepin hydrochloride drug variants containing FD&C GREEN NO. 3
doxepin hydrochloride drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 3
doxepin hydrochloride drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Lifestar Pharma LLC | doxepin hydrochloride | 70756-424 |
| First Nation Group LLC | doxepin hydrochloride | 81469-415 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
doxepin hydrochloride drug variants containing FD&C RED NO. 40
doxepin hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
doxepin hydrochloride drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | doxepin hydrochloride | 42571-420 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
doxepin hydrochloride drug variants containing FD&C YELLOW NO. 6
doxepin hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
doxepin hydrochloride drug variants containing FERRIC OXIDE RED
doxepin hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
doxepin hydrochloride drug variants containing FERRIC OXIDE YELLOW
doxepin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
doxepin hydrochloride drug variants containing FERROSOFERRIC OXIDE
doxepin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
doxepin hydrochloride drug variants containing GELATIN
doxepin hydrochloride drug variants not containing GELATIN
Excipient focus: GLYCERIN
doxepin hydrochloride drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | doxepin hydrochloride | 54838-512 |
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| Carilion Materials Management | doxepin hydrochloride | 68151-5656 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing GLYCERIN
Excipient focus: GLYCERYL MONOSTEARATE
doxepin hydrochloride drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | doxepin hydrochloride | 0093-9609 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8130 |
| Amneal Pharmaceuticals NY LLC | doxepin hydrochloride | 69238-1733 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROCHLORIC ACID
doxepin hydrochloride drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | doxepin hydrochloride | 54838-512 |
| Carilion Materials Management | doxepin hydrochloride | 68151-5656 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: ISOPROPYL ALCOHOL
doxepin hydrochloride drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | doxepin hydrochloride | 62135-560 |
| Leading Pharma LLC | doxepin hydrochloride | 69315-158 |
| Leading Pharma LLC | doxepin hydrochloride | 69315-163 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: ISOPROPYL MYRISTATE
doxepin hydrochloride drug variants containing ISOPROPYL MYRISTATE
doxepin hydrochloride drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: MAGNESIUM STEARATE
doxepin hydrochloride drug variants containing MAGNESIUM STEARATE
doxepin hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
doxepin hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | doxepin hydrochloride | 54838-512 |
| Carilion Materials Management | doxepin hydrochloride | 68151-5656 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
doxepin hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-5390 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
doxepin hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 102
doxepin hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: PEG-10 GLYCERYL STEARATE
doxepin hydrochloride drug variants containing PEG-10 GLYCERYL STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8117 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8123 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing PEG-10 GLYCERYL STEARATE
Excipient focus: PEG-100 STEARATE
doxepin hydrochloride drug variants containing PEG-100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | doxepin hydrochloride | 0093-9609 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8117 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8123 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8130 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing PEG-100 STEARATE
Excipient focus: PEPPERMINT OIL
doxepin hydrochloride drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing PEPPERMINT OIL
Excipient focus: PETROLATUM
doxepin hydrochloride drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8117 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8123 |
| Mylan Pharmaceuticals Inc | doxepin hydrochloride | 0378-8130 |
| Amneal Pharmaceuticals NY LLC | doxepin hydrochloride | 69238-1733 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing PETROLATUM
Excipient focus: POLYETHYLENE GLYCOL 400
doxepin hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYOXYL 100 STEARATE
doxepin hydrochloride drug variants containing POLYOXYL 100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | doxepin hydrochloride | 69238-1733 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing POLYOXYL 100 STEARATE
Excipient focus: POTASSIUM HYDROXIDE
doxepin hydrochloride drug variants containing POTASSIUM HYDROXIDE
doxepin hydrochloride drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
doxepin hydrochloride drug variants containing PROPYLENE GLYCOL
doxepin hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
doxepin hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | doxepin hydrochloride | 54838-512 |
| Carilion Materials Management | doxepin hydrochloride | 68151-5656 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SHELLAC
doxepin hydrochloride drug variants containing SHELLAC
doxepin hydrochloride drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
doxepin hydrochloride drug variants containing SILICON DIOXIDE
doxepin hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
doxepin hydrochloride drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM HYDROXIDE
doxepin hydrochloride drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | doxepin hydrochloride | 54838-512 |
| Carilion Materials Management | doxepin hydrochloride | 68151-5656 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
doxepin hydrochloride drug variants containing SODIUM LAURYL SULFATE
doxepin hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SORBITOL
doxepin hydrochloride drug variants containing SORBITOL
doxepin hydrochloride drug variants not containing SORBITOL
Excipient focus: SORBITOL SOLUTION
doxepin hydrochloride drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | doxepin hydrochloride | 0093-9609 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing SORBITOL SOLUTION
Excipient focus: STARCH, CORN
doxepin hydrochloride drug variants containing STARCH, CORN
doxepin hydrochloride drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
doxepin hydrochloride drug variants containing TITANIUM DIOXIDE
doxepin hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
doxepin hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Morton Grove Pharmaceuticals Inc | doxepin hydrochloride | 60432-651 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
doxepin hydrochloride drug variants containing WATER
doxepin hydrochloride drug variants not containing WATER
Excipient focus: WHITE PETROLATUM
doxepin hydrochloride drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | doxepin hydrochloride | 0093-9609 |
| >Company | >Ingredient | >NDC |
doxepin hydrochloride drug variants not containing WHITE PETROLATUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
